VivoSeq
Other

Large Vessel Occlusion

0

Pipeline Programs↗

2

Active Trials↗

0

Companies Involved↗

Large Vessel Occlusion is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

75/100

Attrition Rate

17/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

6

clinical trials

Completed3 · 50%
Not yet recruiting2 · 33%
Terminated1 · 17%

Clinical Trials

Trial Activity

6 trials

Safety and Efficacy of Baricitinib After Endovascular Treatment in Acute Anterior Circulation Large Vessel Occlusion: A Multicenter, Randomized Controlled Clinical Trial
Not yet recruiting·TThe First Affiliated Hospital of University of Science and Technology of China·Phase 2/3·NCT07449910·750 enrolled
A Randomized Clinical Trial on Urgent Angioplasty for IntraCranial Atherosclerotic Stenosis-related Large-Vessel Occlusion After Mechanical Thrombectomy
Not yet recruiting·—·N/A·NCT06702657·612 enrolled
Direct Intra-arterial Thrombectomy in Order to Revascularize AIS Patients With Large Vessel Occlusion Efficiently in Chinese Tertiary Hospitals
Completed·—·N/A·NCT03469206·656 enrolled
Intravenous Thrombolysis With rhTNK-tPA for Acute Non-large Vessel Occlusion in Extended Time Window
Completed·XXuanwu Hospital, Beijing·Phase 4·NCT05752916·570 enrolled
Impact of Apixaban on Clinical Outcome of the Patients With Large Vessel Occlusion or Stenosis Trial
Completed·HHyogo Medical University·N/A·NCT02818868·700 enrolled
Extending the Time Window for Tenecteplase by Effective Reperfusion in Patients with Large Vessel Occlusion
Terminated·UUniversity of Melbourne·Phase 3·NCT04454788·242 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)